Cortez-Pinto Helena, Machado Mariana
Serviço Nutrição e Metabolismo, Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa e Serviço de Gastrenterologia do Hospital de Santa Maria, Lisboa, Portugal.
Expert Rev Gastroenterol Hepatol. 2008 Apr;2(2):217-31. doi: 10.1586/17474124.2.2.217.
Nonalcoholic steatohepatitis is part of the broader spectrum of nonalcoholic fatty liver disease, strongly associated with insulin resistance, obesity and the metabolic syndrome. Its increasing prevalence appears to be closely related to the increased frequency of overweight or obesity; which is associated with changes in dietary habits, including an increased consumption of hypercaloric food and saturated fat, often concurrent with decreased activity and energy expenditure. Weight loss through dieting and increasing energy expenditure through the practice of regular exercise has been shown to be effective in improving nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, and is considered the mainstay of treatment. The effectiveness of these lifestyle interventions seems to rely chiefly on an improvement in insulin sensitivity. At present, disease management using a multidisciplinary team is probably pivotal for patient-centered quality of care.
非酒精性脂肪性肝炎是非酒精性脂肪性肝病这一更广范畴的一部分,与胰岛素抵抗、肥胖和代谢综合征密切相关。其患病率的不断上升似乎与超重或肥胖发生率的增加密切相关;超重或肥胖与饮食习惯的改变有关,包括高热量食物和饱和脂肪的摄入量增加,且往往同时伴有活动量和能量消耗的减少。通过节食减肥以及通过经常锻炼增加能量消耗已被证明对改善非酒精性脂肪性肝病/非酒精性脂肪性肝炎有效,并且被视为主要治疗方法。这些生活方式干预措施的有效性似乎主要依赖于胰岛素敏感性的改善。目前,采用多学科团队进行疾病管理可能对以患者为中心的医疗质量至关重要。